ERUZENT Trademark

Trademark Overview


On Thursday, June 12, 2008, a trademark application was filed for ERUZENT with the United States Patent and Trademark Office. The USPTO has given the ERUZENT trademark a serial number of 77497620. The federal status of this trademark filing is ABANDONED - EXPRESS AFTER PUB as of Wednesday, January 19, 2011. This trademark is owned by Pfizer Inc.. The ERUZENT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction and pain; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use
eruzent

General Information


Serial Number77497620
Word MarkERUZENT
Filing DateThursday, June 12, 2008
Status605 - ABANDONED - EXPRESS AFTER PUB
Status DateWednesday, January 19, 2011
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 11, 2008

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of erectile dysfunction, sexual dysfunction and pain; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code8 - Abandoned
Class Status DateWednesday, January 19, 2011
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events


Event DateEvent Description
Wednesday, January 19, 2011ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
Wednesday, January 19, 2011ABANDONMENT - AFTER PUBLICATION
Wednesday, January 19, 2011TEAS EXPRESS ABANDONMENT RECEIVED
Tuesday, August 3, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 2, 2010EXTENSION 3 GRANTED
Tuesday, July 27, 2010EXTENSION 3 FILED
Tuesday, July 27, 2010TEAS EXTENSION RECEIVED
Tuesday, March 9, 2010EXTENSION 2 GRANTED
Friday, January 29, 2010EXTENSION 2 FILED
Tuesday, March 9, 2010CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, January 29, 2010TEAS EXTENSION RECEIVED
Tuesday, July 14, 2009EXTENSION 1 GRANTED
Tuesday, July 14, 2009EXTENSION 1 FILED
Tuesday, July 14, 2009TEAS EXTENSION RECEIVED
Tuesday, February 3, 2009NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 11, 2008PUBLISHED FOR OPPOSITION
Wednesday, October 22, 2008NOTICE OF PUBLICATION
Monday, October 6, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, October 6, 2008ASSIGNED TO LIE
Wednesday, September 24, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 19, 2008ASSIGNED TO EXAMINER
Monday, June 16, 2008NEW APPLICATION ENTERED IN TRAM